Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease

被引:51
|
作者
Stumpf, Sina K. [1 ]
Berghoff, Stefan A. [1 ]
Trevisiol, Andrea [1 ]
Spieth, Lena [1 ]
Dueking, Tim [1 ]
Schneider, Lennart V. [1 ]
Schlaphoff, Lennart [1 ]
Dreha-Kulaczewski, Steffi [2 ]
Bley, Annette [3 ]
Burfeind, Dinah [1 ]
Kusch, Kathrin [1 ]
Mitkovski, Miso [4 ]
Ruhwedel, Torben [1 ,5 ]
Guder, Philipp [3 ]
Roehse, Heiko [4 ]
Denecke, Jonas [3 ]
Gaertner, Jutta [2 ]
Moebius, Wiebke [1 ,5 ,6 ]
Nave, Klaus-Armin [1 ,5 ,6 ]
Saher, Gesine [1 ]
机构
[1] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany
[2] Univ Med Ctr, Dept Pediat & Adolescent Med, Div Pediat, D-37075 Gottingen, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Univ Childrens Hosp, D-20246 Hamburg, Germany
[4] Max Planck Inst Expt Med, Light Microscopy Facil, D-37075 Gottingen, Germany
[5] Max Planck Inst Expt Med, Electron Microscopy Core Unit, D-37075 Gottingen, Germany
[6] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany
基金
欧洲研究理事会;
关键词
Ketogenic diet; Myelin; Pelizaeus-Merzbacher disease; Remyelination; Axonal degeneration; Mitochondria; MULTIPLE-SCLEROSIS; PROTEOLIPID PROTEIN; MAGNETIZATION-TRANSFER; BRAIN CHOLESTEROL; KETONE-BODIES; MOUSE MODEL; DEMYELINATION; CUPRIZONE; MICE; OLIGODENDROCYTES;
D O I
10.1007/s00401-019-01985-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pelizaeus-Merzbacher disease (PMD) is an untreatable and fatal leukodystrophy. In a model of PMD with perturbed blood-brain barrier integrity, cholesterol supplementation promotes myelin membrane growth. Here, we show that in contrast to the mouse model, dietary cholesterol in two PMD patients did not lead to a major advancement of hypomyelination, potentially because the intact blood-brain barrier precludes its entry into the CNS. We therefore turned to a PMD mouse model with preserved blood-brain barrier integrity and show that a high-fat/low-carbohydrate ketogenic diet restored oligodendrocyte integrity and increased CNS myelination. This dietary intervention also ameliorated axonal degeneration and normalized motor functions. Moreover, in a paradigm of adult remyelination, ketogenic diet facilitated repair and attenuated axon damage. We suggest that a therapy with lipids such as ketone bodies, that readily enter the brain, can circumvent the requirement of a disrupted blood-brain barrier in the treatment of myelin disease.
引用
收藏
页码:147 / 161
页数:15
相关论文
共 50 条
  • [1] Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
    Sina K. Stumpf
    Stefan A. Berghoff
    Andrea Trevisiol
    Lena Spieth
    Tim Düking
    Lennart V. Schneider
    Lennart Schlaphoff
    Steffi Dreha-Kulaczewski
    Annette Bley
    Dinah Burfeind
    Kathrin Kusch
    Miso Mitkovski
    Torben Ruhwedel
    Philipp Guder
    Heiko Röhse
    Jonas Denecke
    Jutta Gärtner
    Wiebke Möbius
    Klaus-Armin Nave
    Gesine Saher
    Acta Neuropathologica, 2019, 138 : 147 - 161
  • [2] Correction to: Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
    Sina K. Stumpf
    Stefan A. Berghoff
    Andrea Trevisiol
    Lena Spieth
    Tim Düking
    Lennart V. Schneider
    Lennart Schlaphoff
    Steffi Dreha-Kulaczewski
    Annette Bley
    Dinah Burfeind
    Kathrin Kusch
    Miso Mitkovski
    Torben Ruhwedel
    Philipp Guder
    Heiko Röhse
    Jonas Denecke
    Jutta Gärtner
    Wiebke Möbius
    Klaus-Armin Nave
    Gesine Saher
    Acta Neuropathologica, 2019, 138 : 673 - 674
  • [3] Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease (vol 138, pg 147, 2019)
    Stumpf, Sina K.
    Berghoff, Stefan A.
    Trevisiol, Andrea
    Spieth, Lena
    Dueking, Tim
    Schneider, Lennart V.
    Schlaphoff, Lennart
    Dreha-Kulaczewski, Steffi
    Bley, Annette
    Burfeind, Dinah
    Kusch, Kathrin
    Mitkovski, Miso
    Ruhwedel, Torben
    Guder, Philipp
    Roehse, Heiko
    Denecke, Jonas
    Gaertner, Jutta
    Moebius, Wiebke
    Nave, Klaus-Armin
    Saher, Gesine
    ACTA NEUROPATHOLOGICA, 2019, 138 (04) : 673 - 674
  • [4] Myelination of a fetus with Pelizaeus-Merzbacher disease: Immunopathological study
    Shiraishi, K
    Itoh, M
    Sano, K
    Takashima, S
    Kubota, T
    ANNALS OF NEUROLOGY, 2003, 54 (02) : 259 - 262
  • [5] Pelizaeus-Merzbacher disease
    Hodes, ME
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 27 (01) : 50 - 54
  • [6] Pelizaeus-Merzbacher Disease
    Kumar R.
    Aneja S.
    Taluja V.
    Agarwal A.
    Mahajan H.
    The Indian Journal of Pediatrics, 1997, 64 (5) : 705 - 709
  • [7] Pelizaeus-Merzbacher disease
    Koeppen, AH
    Robitaille, Y
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (09): : 747 - 759
  • [8] PELIZAEUS-MERZBACHER DISEASE
    GOUTIERES, F
    AICARDI, J
    BOULLOCHE, J
    NEUROPEDIATRICS, 1987, 18 (02) : 116 - 116
  • [9] Pelizaeus-Merzbacher disease
    Anderson, TJ
    Griffiths, IR
    LABORATORY ANIMAL SCIENCE, 1999, 49 (01): : 54 - 57
  • [10] PELIZAEUS-MERZBACHER DISEASE
    ZEMAN, W
    DEMYER, W
    FALLS, HF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1964, 23 (02): : 334 - +